The clinical observation for Triamcinolone acetonide vitreous injection on retinal vein occlusion secondary macula edema

Objective:To evaluate the effect and safety of TriamcinoloneAcetonide(TA) vitreousinjectiononretinalveinocclusionsecondary macula edema. Methods: Forty-two cases( 42 eyes) with retinal vein occlusion secondary macula edema were diagnosed with indirective ophthalmoscope, fluorescence fundus angiography ( FFA) and optical coherence tomography( OCT) ,and of which received TA 0. 1ml( 4mg) vitreous injection. The visual acuity,intraocular pressure,fundus,FFA,and OCT on macula were examined before-and after-operation,and with 6 months follow-up. Results: Twenty-five eyes with central retinal vein occlusion( 17 eyes with ischemic central retinal vein occlusion and 8 eyes with un-ischemic) ,17 eyes with branch retinal vein occlusion( 11 eyes with ischemic central retinal vein occlusion and 6 eyes with un-ischemic) . By the end of follow-up,visual acuity increased in 30 eyes,no changed 7 eyes,and decreased 5 eyes. The pattern of OCT recovered in 16 eyes ,improved in 23 eyes,no improved in 3 eyes. Intraocula pressure increased temporary was fund in 11 cases. In 1 case,TA granule attached to post-capsula and disappeared after 1 month. Conclution: TA vitreous injection is safe and effective for retinal vein occlusion secondary macula edema.